GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » Total Long-Term Assets

Tasly Pharmaceutical Group Co (SHSE:600535) Total Long-Term Assets : ¥7,943 Mil (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Tasly Pharmaceutical Group Co Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Tasly Pharmaceutical Group Co's Total Long-Term Assets for the quarter that ended in Mar. 2024 was ¥7,943 Mil.

Tasly Pharmaceutical Group Co Total Long-Term Assets Historical Data

The historical data trend for Tasly Pharmaceutical Group Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tasly Pharmaceutical Group Co Total Long-Term Assets Chart

Tasly Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,471.06 7,473.04 7,292.25 7,216.70 7,981.60

Tasly Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,068.62 8,168.81 8,230.01 7,981.60 7,943.17

Tasly Pharmaceutical Group Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Tasly Pharmaceutical Group Co Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Tasly Pharmaceutical Group Co's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tasly Pharmaceutical Group Co (SHSE:600535) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » Total Long-Term Assets
Comparable Companies
SZSE:300601 SHSE:600380 SHSE:600521 SHSE:600329 SZSE:300142 SHSE:600062 SHSE:603707 SZSE:002262 SHSE:600867 SHSE:600129 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410
Website
http://www.tasly.com
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.

Tasly Pharmaceutical Group Co (SHSE:600535) Headlines

No Headlines